Skip to content
Home/Companies/Biotech/Dewpoint Therapeutics
DT

Dewpoint Therapeutics

Biotech·United States·Active·7yr hold

Dewpoint Therapeutics is a healthcare company, headquartered in USA.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Dewpoint Therapeutics?

Dewpoint Therapeutics is currently owned by Leaps by Bayer through Leaps by Bayer (2015 vintage), since 2019. Across its history, Dewpoint Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Leaps by Bayer
Most recent investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen
2 ownership periods · full history below

Key facts

HQUSA
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Leaps by Bayer and Mubadala Capital since 2019.
Co-invest · 2 holders · 2019 · present
Leaps by Bayer
Leaps by BayerActive
2019 · present · Leaps by Bayer · 2015 · Evergreen
MOIC
–
Mubadala Capital
Mubadala CapitalActive
2019 · present · Mubadala Capital Other Investments · Buyout
MOIC
–

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Active
BiotechUnited States· 2026
Leaf Agriculture
Active
ClimateTechUnited States· 2026
Sabanto
Active
AgTechUnited States· 2026
SonoThera
Active
BiotechUnited States· 2026
Souffle Therapeutics
Active
BiotechUnited States· 2025
WellTheory
Active
HealthTechUnited States· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings